Opca Bolnica Virovitica
- Address
- lock Available on a paid plan
Opca Bolnica Virovitica - Inflammatory Bowel Disease Research
Opca Bolnica Virovitica is a medical research center engaged in clinical investigation of innovative therapeutic approaches for inflammatory bowel diseases. The center participates in advanced clinical trials focusing on novel biologic therapies for patients with chronic gastrointestinal inflammatory conditions.
- Phase 2 clinical trials evaluating novel biologics for Crohn's Disease
- Endoscopic assessment and monitoring of inflammatory bowel disease activity
- Treatment strategies for moderately to severely active inflammatory conditions
The research center specializes in evaluating endoscopic response as a critical endpoint in Crohn's Disease treatment studies. Their expertise encompasses the comprehensive management of patients with moderate to severe disease activity, contributing to the development of next-generation therapies designed to improve outcomes for individuals living with inflammatory bowel disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Morphic Therapeutic Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 60 other sites in Croatia
Therapeutic Area Benchmark — Croatia
Select a therapeutic area to compare against other sites in Croatia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Croatia
Market Share
Country: Croatia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Opca Bolnica Virovitica
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of MORF-057 Efficacy and Safety in Adults with Moderately to Severely Active Crohn's Disease: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study | Morphic Therapeutic Inc. | Phase II | Recruiting | Jun 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Morf-057 | 1 | Unknown | 2024-06-25 | 2024-06-25 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.